RATIONAL TREATMENT OF ACUTERESPIRATORY VIRAL INFECTION USING THE DRUG SEPTOLETE® TOTAL

Acute respiratory viral infections (ARVI) are the most common diseases of the human population. Due to the high virulence of pathogens, in some cases they can acquire the character of an epidemic or pandemic. The diversity of the clinical picture, the com- plexity of predicting outcomes makes the problem of rational choice of a drug for the primary treatment of acute respiratory viral infections a key one and poses a difficult task for the pharmacist - the correct, efficient, safe and effective use of a wide range of drugs available on the domestic pharmaceutical market for the treatment of acute respiratory viral infections. During the pharma- cy consultation, the pharmacist has to find out the patient’s complaints, his morbid background, the presence of drug intolerance, as well as a number of other factors, taking into account the pandemic of a new coronavirus infection. Medicines for the treatment of acute respiratory viral infections are presented in most cases as combination drugs that have several mechanisms of action. The possibility of influencing several manifestations of the disease is provided through the use of Septolete® Total, which has not only a favorable efficacy / safety profile, but also distinct economic advantages over analogues, as well as a potential virucidal effect against the causative agent of a new coronavirus COVID-19 infections.